Jump to content


Did you know that exercise increases inflammation in systemic sclerosis?


Photo

Anti-MDA5 is associated with rapidly progressive lung disease and poor survival in U.S. patients with amyopathic (CADM) and myopathic dermatomyositis (DM).

myopathy myositis

  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,610 posts
  • Location:West Sussex

Posted 28 November 2015 - 10:38 AM

Anti-MDA5 is associated with rapidly progressive lung disease and poor survival in U.S. patients with amyopathic (CADM) and myopathic dermatomyositis (DM).

 

Anti-MDA5 antibody is significantly associated with interstitial lung disease, rapidly progressing interstitial lung disease, worse pulmonary outcome, and survival in US classic DM and CADM patients. PubMed, Arthritis Care Res (Hoboken), 09/28/2015. (Also see Myopathy and Myositis)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)






Also tagged with one or more of these keywords: myopathy, myositis